Restatement of Net Asset Value(s)

Summary by AI BETAClose X

International Biotechnology Trust PLC has restated its unaudited cum income net asset value per share for several dates between December 29, 2025, and January 19, 2026, due to an administrative error concerning the non-accrual of an interim dividend. For example, the published NAV per share on December 29, 2025, was 1021.50, which has been revised to 1005.87. Similarly, the NAV on January 19, 2026, was revised from 1009.70 to 994.04. The company's service providers have implemented corrective measures and enhanced their procedures following this adjustment.

Disclaimer*

UK 100

Latest directors dealings